Primary record
US9522910, Table 1 Compound 1: 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-(2-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethynyl)benzamide
- 库存
- 8,183 克
- 纯度
- 98.2 %
- CAS
- 1416241-23-0
化合物标识与属性
- CAS
- 1416241-23-0
- PubChem CID
- 71475839
- SMILES
- CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=NN=C5N4C=CC=C5
- Canonical SMILES
- Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1nnc2ccccn12
名称与同义词
- Vamotinib
- vamotinib [INN]
- PF-114
- I8C3R768IZ
- RefChem:172271
- UNII-I8C3R768IZ
- 1416241-23-0
- Bcr-Abl Inhibitor PF-114
- GTPL9792
- orb1686292
- CHEMBL4297478
- SCHEMBL15789568
- SCHEMBL29441255
- SLIVDYMORZGPLW-UHFFFAOYSA-N
- PF114
- Bcr-Abl Kinase Inhibitor PF-114
- DB15396
- DA-78825
- MS-29841
- HY-147414
- CS-0564153
- J3.760.003B
- compound 1 (Table 1) [WO2012173521]
- H38689
- A1246873
- Benzamide, 4-methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1,2,4-triazolo(4,3-a)pyridin-3-yl)ethynyl)-
- 3-([1,2,4]Triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
- 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-(2-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethynyl)benzamide
- 4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-((1,2,4)triazolo(4,3-a)pyridin-3-yl)ethynyl)benzamide
- 4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethynyl]benzamide
- 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-[([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethynyl]benzamide
- US9522910, Table 1 Compound 1: 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-(2-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethynyl)benzamide